ERBB2 and breast cancer: Genomic studies have established that breast cancer can be divided into 4 major intrinsic subtypes (Luminal-A, Luminal-B, HER2-enriched, triple negative) that differ significantly in terms of incidence, survival, and response to therapy [11, 12].